phase readout

NCT07138209: A Study Comparing QLS32015 Monotherapy Versus Pomalidomide, Dexamethasone (Pd) or Selinexor, Dexamethasone (Sd) in Participants With Relapsed or Refractory Multiple Myeloma

RECRUITINGupdated 56m ago

community read0 votes

Sponsor: Qilu Pharmaceutical Co., Ltd.. Phase: PHASE3. Conditions: Relapsed or Refractory Multiple Myeloma

Data sources

last refreshed 56m ago

Found something off?

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?